FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's raloxifene hydrochloride generic as an Original Application (ANDA), enabling a generic product for postmenopausal osteoporosis and for r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer
• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

ORIG AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)